Showing 1 - 10 of 246
We extend prior research on the effect of managed care on the receipt of four medical interventions for pregnant women: ultrasound, induction/stimulation of birth, electronic fetal monitor, and cesarean delivery. Propensity score methods are used to account for sample selection issues regarding...
Persistent link: https://www.econbiz.de/10005822744
This primer aims to provide IMF macroeconomists with the essential information they need in situations where they must address issues concerning health sector policy and when they have significant macroeconomic implications. Such issues can also affect equity and growth and are fundamental to...
Persistent link: https://www.econbiz.de/10005825737
American Academic medicine--the system of education and research that trains the coming generations of physicians, produces new basic and clinical bio-medical research and provides the medical safety net in many U.S. urban areas--is in a funding crisis. This essay lays out an historical and...
Persistent link: https://www.econbiz.de/10009200357
Persistent link: https://www.econbiz.de/10010677771
We provide a modeling framework to think about selective contracting in the health care sector. Two health care providers differ in quality and costs. When buying health insurance, consumers observe neither provider quality nor costs. We derive an equilibrium where health insurers signal...
Persistent link: https://www.econbiz.de/10011146224
Persistent link: https://www.econbiz.de/10011261947
I develop a new approach for sample selection problems that allows parametric forms of any type to be chosen for both for the selection and the observed variables. The Generalized Parametric Selection (GPS) model can incorporate both duration and count data models, unlike previous parametric...
Persistent link: https://www.econbiz.de/10008620310
States have increasingly used Health Maintenance Organizations (HMOs) to provide medical services to the Medicaid population. However, the effects of these initiatives on total health-care expenses, the mix of utilization, and access to care remain unclear. We examine the effect of changes in...
Persistent link: https://www.econbiz.de/10008925740
Persistent link: https://www.econbiz.de/10009213622
Scherer (Scherer, F.M., "How US Antitrust Can Go Astray: The Brand Name Prescription Drug Litigation", International Journal of the Economics of Business, 1997, 4, 3, 000-000) uses the conventional economic model of third-degree price discrimination to analyze the pharmaceutical industry's...
Persistent link: https://www.econbiz.de/10009213657